全文获取类型
收费全文 | 68308篇 |
免费 | 5178篇 |
国内免费 | 1198篇 |
专业分类
耳鼻咽喉 | 745篇 |
儿科学 | 1225篇 |
妇产科学 | 1075篇 |
基础医学 | 8716篇 |
口腔科学 | 959篇 |
临床医学 | 6971篇 |
内科学 | 15189篇 |
皮肤病学 | 712篇 |
神经病学 | 5987篇 |
特种医学 | 2650篇 |
外国民族医学 | 5篇 |
外科学 | 10293篇 |
综合类 | 2729篇 |
现状与发展 | 1篇 |
一般理论 | 71篇 |
预防医学 | 4635篇 |
眼科学 | 1402篇 |
药学 | 4848篇 |
15篇 | |
中国医学 | 789篇 |
肿瘤学 | 5667篇 |
出版年
2024年 | 59篇 |
2023年 | 463篇 |
2022年 | 637篇 |
2021年 | 2205篇 |
2020年 | 1438篇 |
2019年 | 1827篇 |
2018年 | 2192篇 |
2017年 | 1614篇 |
2016年 | 1686篇 |
2015年 | 2151篇 |
2014年 | 3027篇 |
2013年 | 3320篇 |
2012年 | 5478篇 |
2011年 | 5442篇 |
2010年 | 3239篇 |
2009年 | 2803篇 |
2008年 | 4520篇 |
2007年 | 4699篇 |
2006年 | 4557篇 |
2005年 | 4450篇 |
2004年 | 3913篇 |
2003年 | 3635篇 |
2002年 | 3300篇 |
2001年 | 767篇 |
2000年 | 613篇 |
1999年 | 726篇 |
1998年 | 766篇 |
1997年 | 687篇 |
1996年 | 544篇 |
1995年 | 512篇 |
1994年 | 372篇 |
1993年 | 339篇 |
1992年 | 252篇 |
1991年 | 220篇 |
1990年 | 190篇 |
1989年 | 164篇 |
1988年 | 152篇 |
1987年 | 124篇 |
1986年 | 116篇 |
1985年 | 138篇 |
1984年 | 142篇 |
1983年 | 116篇 |
1982年 | 141篇 |
1981年 | 121篇 |
1980年 | 105篇 |
1979年 | 61篇 |
1978年 | 66篇 |
1977年 | 64篇 |
1976年 | 57篇 |
1974年 | 52篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
Evaluation of NMU-Induced Breast Cancer Treated with Sirolimus and Sunitinib on Breast Cancer Growth 下载免费PDF全文
Nurul Fathiyatul Nabila JaffarMuhammad Shahidan Muhammad SakriHasnan JaafarWan Faiziah Wan Abdul RahmanTengku Ahmad Damitri Al-Astani Tengku Din 《Asian Pacific journal of cancer prevention》2020,21(10):2919-2925
Objective: To analyze the effect of sirolimus and sunitinib in blocking the tumor growth and to evaluate the expressions of estrogen receptor (ER), progesterone receptor (PgR), and human epidermal growth factor receptor-2 (HER2/neu) after treated with sirolimus and sunitinib. Methods: Thirty-two female Sprague Dawley rats at age 21-days old were administered intraperitoneally with N-Methyl-N-Nitroso Urea (NMU), dosed at 70mg/kg body weight. The rats were divided into 4 groups; Group 1 (Control, n=8), Group 2 (Sirolimus, n=8), Group 3 (Sunitinib, n=8) and Group 4 (Sirolimus+Sunitinib, n=8), being treated twice when the tumor reached the size of 14.5±0.5 mm and subsequently sacrificed after 5 days. The protein expressions of ER, PgR and HER2/neu of the tumor tissues were evaluated by using immunohistochemistry analysis. Results: Treatment with sirolimus alone lowered expressions of ER and PgR of breast cancer and reduced tumor size. There was no significant difference of ER and PgR expressions between control and sunitinib treated tumor. Sunitinib treated tumors reduce in diameter after the first treatment, however the diameter increases after the second treatment. Histologically, sunitinib treated tumor did not show any aggressive invasive carcinoma of no special type (NST) histological subtypes. In addition, all NMU-induced tumors are HER2/neu-negative scoring. Conclusion: Sirolimus is neither synergistic nor additive with sunitinib for breast cancer treatment. 相似文献
42.
Babiker Hani M. Milhem Mohammed Aisner Joseph Edenfield William Shepard Dale Savona Michael Iyer Swaminathan Abdelrahim Maen Beach C. L. Skikne Barry Laille Eric Tsai Kao-Tai Ho Thai 《Cancer chemotherapy and pharmacology》2020,85(3):621-626
Cancer Chemotherapy and Pharmacology - CC-486 is an oral formulation of azacitidine that allows for extended dosing schedules to prolong azacitidine exposure to malignant cells and maximize... 相似文献
43.
44.
Zhengxian Huang Nan Xie Haichao Liu Yuehan Wan Yue Zhu Ming Zhang Yifan Tao Han Zhou Xiqiang Liu Jinsong Hou Cheng Wang 《Journal of oral pathology & medicine》2019,48(9):788-798
It has been suggested that tumour‐infiltrating lymphocytes (TILs) are associated with the progression of oral squamous cell carcinoma (OSCC). However, the prognostic value of TILs is inconclusive due to the heterogeneity of immune cells within the tumour microenvironment. In this meta‐analysis, we aimed to assess the prognostic value of TILs in OSCC. The PubMed, Cochrane, Embase, Scopus and Web of Science databases were searched up to April 20, 2019, and 33 studies were ultimately included in this meta‐analysis. Our pooled meta‐analysis showed that high infiltration of CD8+ TILs, CD45RO+ TILs and CD57+ TILs favoured better overall survival (OS). However, high infiltration of CD68+ macrophages and CD163+ macrophages was associated with poor prognosis in OSCC. These findings suggest that CD8+ TILs, CD45RO+ TILs, CD57+ TILs, CD68+ macrophages and CD163+ macrophages might serve as novel prognostic factors and therapeutic targets in OSCC. 相似文献
45.
46.
47.
48.
49.
喘鸣是婴幼儿时期呼吸道疾病中最常见的症状,病因很多,并非所有的喘鸣均由哮喘引起。气管、支气管炎及气管、支气管软骨软弱、异物、血管畸形,胸内肿瘤以及支气管淋巴结核等,均可引起喘鸣。分析天津市儿童医院收治的以喘鸣为主要症状的3岁以下婴幼儿196例,其主要病因见表1。表1天津市儿童医院收治的196例以喘鸣为主要症状的婴幼儿喘鸣病因病因例数大气道阻塞气管、支气管异物21气管、支气管淋巴结核51先天性气管、支气管、肺发育畸形12支气管软骨软化3纵隔囊肿和(或)肿瘤19血管畸形1中叶综合征5小气道阻塞毛细支气管炎30以喘息为表型的婴幼… 相似文献
50.
通过历时2 a的现场监测,揭示了大面积堆场逐级增高情况下软土地基变形特性的规律,总结了固结沉降的规律,为软土地基的固结沉降分析计算提供依据. 相似文献